Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Important Progress in the Fight against Testicular Cancer

25.03.2019

Researchers at the University of Bremen have made great progress in the fight against testicular cancer. An important biomarker has been developed further in a comprehensive study and is almost ready for clinical application. The results have now been published in a prestigious scientific journal.

Testicular cancer is the most common malignant tumor in young men between 20 and 40 years of age. Determining the concentration of so-called biomarkers in patients’ blood is an important tool for assessing the course of the disease – but for a long time doctors lacked reliable biomarkers.


Successful in the further development of a biomarker for testicular cancer detection: Dr. Arlo Radtke (left) and PD Dr. Ganzafer Belge from the Faculty of Biology at the University of Bremen

Kai Uwe Bohn / University of Bremen


Successful in the further development of a biomarker for testicular cancer detection: PD Dr. Ganzafer Belge (left) and Dr. Arlo Radtke from the Faculty of Biology at the University of Bremen

Kai Uwe Bohn / University of Bremen

A first important step forward was therefore the discovery of an extremely promising biomarker in 2012. A working group led by human geneticist Dr. Gazanfer Belge from the University of Bremen demonstrated the effectiveness of this marker in eleven patients with testicular cancer.

37 European Clinics Involved

Even though a first step has been made in medical research, many more generally have to follow before an important discovery one day ends up in clinical routine. “No doctor in the world will rely on biomarkers that have been tested on only a dozen patients,” says Belge.

The startling discovery seven years ago prompted the Wilhelm Sander-Stiftung für Krebsforschung (foundation for cancer research) to set up a follow-up project funded with 170,000 euros. The third-party funding enabled a multiyear, multicenter study in which 37 urology and oncology clinics in various European countries participated.

“Over the past three years, the biomarker has been tested on more than 600 patients and has undergone considerable further development,” said the human geneticist.

The result was that the biomarker, which was researched and developed at the University of Bremen, is now extremely sensitive and therefore highly accurate. “After testicular cancer treatment with chemotherapy or radiation, success is checked with the help of imaging procedures and blood tests.

The biomarker we developed correctly indicates, in 94% of healthy cases, that the patients treated are actually negative for germ cell tumors,” explains Dr. Arlo Radtke, who conducted the study together with Gazanfer Belge. “For the medical sector, this means a very good detection rate. The study has shown that the biomarker is a safe tool for both initial diagnosis and post-treatment monitoring.”

183,000 Euros for Follow-Up Study

On the clinical side, Professor Klaus-Peter Dieckmann from the Asklepios Hodentumorzentrum West (testicular tumor center) in Hamburg-Altona was one of the most important medical experts involved. He confirms the high efficacy of the biomarker named miR-371-3p: “From a practitioner’s point of view, the new tumor marker is an important tool in the aftercare of testicular cancer patients.”

Due to the renewed positive results, the Deutsche Krebshilfe foundation has decided to finance another follow-up study with 183,000 euros. The project will run for two years and aims to clinically establish the biomarker for the aftercare of testicular tumor patients.

Dr. Arlo Radtke will also be involved in the important step from feasibility in the laboratory to creating a marketable product ready for application. After completing the study, which was financed by the Wilhelm Sander-Stiftung, he joined the team of the young start-up miRdetect GmbH, which plans to market the new serous tumor marker for testicular cancer.

The company was founded with the help of existing federal funding by the former Bremen university researchers Meike Spiekermann and Nina Winter. Both had worked together with Gazanfer Belge until 2015.

Publication in Prestigious Scientific Journal

The results of the Bremen study have attracted a great deal of attention among experts and have now been published in the Journal of Clinical Oncology. With an impact factor of 26.3, the publication is one of the most important scientific journals in the world. The number reflects the influence of a scientific journal and shows how often the articles of a particular journal are cited in other publications.

Additional Information:

Article in the Journal of Clinical Oncology: http://ascopubs.org/doi/abs/10.1200/JCO.18.01480
www.uni-bremen.de

Contact:

PD Dr. Gazanfer Belge
University of Bremen
Department of Biology/Chemistry
Tel.: +49 421 218-61570
E-mail: belge@uni-bremen.de

Wissenschaftliche Ansprechpartner:

PD Dr. Gazanfer Belge
University of Bremen
Department of Biology/Chemistry
Tel.: +49 421 218-61570
E-mail: belge@uni-bremen.de

Originalpublikation:

http://ascopubs.org/doi/abs/10.1200/JCO.18.01480

Kai Uwe Bohn | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht New eDNA technology used to quickly assess coral reefs
18.04.2019 | University of Hawaii at Manoa

nachricht New automated biological-sample analysis systems to accelerate disease detection
18.04.2019 | Polytechnique Montréal

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

Im Focus: Researchers 3D print metamaterials with novel optical properties

Engineers create novel optical devices, including a moth eye-inspired omnidirectional microwave antenna

A team of engineers at Tufts University has developed a series of 3D printed metamaterials with unique microwave or optical properties that go beyond what is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

New automated biological-sample analysis systems to accelerate disease detection

18.04.2019 | Life Sciences

Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

18.04.2019 | Physics and Astronomy

New eDNA technology used to quickly assess coral reefs

18.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>